|
Sign In to gain access to subscriptions and/or personal tools.
|
Nitric oxide mediates inhibitory effect of losartan on angiotensin-induced contractions in hamster but not rat aorta
Kiyo Inoue
Third Department of Internal Medicine, Osaka Medical College 2-7 Daigakumachi, Takatsuki City, Osaka 569-8686, Japan
Hikaru Nishimura
Third Department of Internal Medicine, Osaka Medical College 2-7 Daigakumachi, Takatsuki City, Osaka 569-8686, Japan, in3023{at}poh.osaka-med.ac.jp
Jiro Kubota
Third Department of Internal Medicine, Osaka Medical College 2-7 Daigakumachi, Takatsuki City, Osaka 569-8686, Japan
Yasushi Kitaura
Third Department of Internal Medicine, Osaka Medical College 2-7 Daigakumachi, Takatsuki City, Osaka 569-8686, Japan
We investigated a possible contribution of nitric oxide (NO) and prostaglandins to the inhibitory effect of losartan on contractions to Ang I (10-6 M) and Ang II (10 -7 M) with or without L-NAME (10-4 M) or indomethacin (10 -5 M) in the aorta of WKY, SHR and hamster (n=7 each). Rings of thoracic aorta (2-mm long) were placed in a myograph (5 ml). Endothelium-dependent vasodilations were evaluated with acetylcholine (10-8 ~ 10 -6 M). After a 45-minute incubation with L-NAME under a resting tension of 2 g, only hamster aorta contracted (p<0.01). The SHR aorta showed impaired relaxations to acetylcholine compared with the WKY and hamster aorta (p<0.05). Despite the difference in the stimulated NO release, losartan completely abolished the responses to Ang I and Ang II both in WKY and SHR vessels irrespective of the presence of L-NAME. In contrast to the rat aorta, the inhibitory effect of losartan was attenuated in the presence of L-NAME in the hamster aorta (78% vs 99% inhibition, p<0.05). Indomethacin did not alter the effect of losartan in any vessels. Our results suggest that the presence of NO, particularly a basal secretion of NO, is necessary for the full expression of the inhibitory effect of losartan in the hamster, but not in WKY or SHR, aorta. Unlike NO, prostaglandins do not appear to play a role in the effect of losartan.
Key Words: angiotensin I • angiotensin II • losartan • aorta • nitric oxide
References
- GradmanAH,Arcuri KE, Goldberg AI et al.A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 1994; 25: 1345-50.[Web of Science]
- Ohlstein EH, Gellai M., Brooks DP et al.The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be solely due to angiotensin II receptor antagonism. J Pharmacol & Experiment Ther 1992; 262: 595-601.[Abstract/Free Full Text]
- Cachofeiro V., Sakakibara T., Nasjletti A. Kinins, nitric oxide, and the hypotensive effect of captopril and ramiprilat in hypertension. Hypertensin 1992;19: 138-45.
- Corriu C., Bernard S., Schott C., Stoclet JC Effects of losartan on contractile responses of conductance and resistance arteries from rats. J Cardiovasc Pharmacol 1995; 26:688-92.[Web of Science][Medline]
[Order article via Infotrieve]
- Inoue K., Nishimura H., Kubota J., Kawamura K. Alternative angiotensin II formation in rat arteries occurs only at very high concentrations of angiotensin I. Hypertension 1999; 34: 525-30.[Abstract/Free Full Text]
- Nishimura H., Buikema H., Baltatu O., Ganten D., Urata H. Functional evidence for alternative Ang II-forming pathways in hamster cardiovascular system. Am J Physiol 1998; 275: H1307-12.[Web of Science][Medline]
[Order article via Infotrieve]
- Takai S., Shiota N., Yamamoto D., Okunishi H., Miyazaki M. Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch. Life Sci 1996; 58: 591-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Morsing P.,Adler G., Brandt-Eliasson U. et al. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin. Hypertension 1999; 33: 1406-1413.[Abstract/Free Full Text]
- Cachofeiro V., Maeso R., Rodrigo E., Navarro J., Ruilope LM, Lahera V. Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension 1995; 26: 236-43.[Abstract/Free Full Text]
- Campbell DJ, Kladis A., Valentijin AJ Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme. J Cardiovas Pharmacol 1995; 26: 233-40.[Web of Science][Medline]
[Order article via Infotrieve]
- Cockcroit JR, Sciberras DG, Goldberg MR, Ritter JM Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm. J Cardiovasc Pharmacol 1993; 22: 579-84.[Web of Science][Medline]
[Order article via Infotrieve]
- Dicpinigaitis PV, Sciberras DG, Goldberg MR, Gayle YE, Rosenstreich DL Losartan-induced bronchospasm. J Allergy Clin Immunol 1996; 98: 1128-30.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- van Rijinsoever EW, Kwee-Zuiderwijk WJM.Angioneurotic edema attributed to the use of losartan. Arch Intern Med 1998; 158:2063-65.[Abstract/Free Full Text]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 1, No. 2,
180-183 (2000)
DOI: 10.3317/jraas.2000.023
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
|
|
